ClinicalTrials.Veeva

Menu

The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children

S

Second Affiliated Hospital of Wenzhou Medical University

Status

Not yet enrolling

Conditions

Short Stature

Treatments

Drug: GnRHa
Drug: PEG-rhGH

Study type

Interventional

Funder types

Other

Identifiers

NCT06768411
SAHoWMU-CR2024-06-223

Details and patient eligibility

About

This study is dedicated to addressing the lack of research on the most effective dosage of long-acting growth hormone for children with short stature. By employing clinical trial design, we are committed to investigating the therapeutic benefits and safety profiles associated with varying doses of long-acting growth hormone. Our ultimate goal is to offer clinicians more precise treatment guidance and assist patients in attaining optimal growth and developmental outcomes.

Enrollment

240 estimated patients

Sex

All

Ages

1 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with short stature or a genetic target height below 2 standard deviations;
  2. Individuals who are pre-pubertal (Tanner stage I) and pubertal (Tanner stages II-IV).
  3. Legal guardians consenting to participate in the study and signing informed consent forms.

Exclusion criteria

  1. Known or suspected hypersensitivity reactions to the investigational product or related products;
  2. Presence of severe systemic diseases;
  3. Patients with malignant tumors;
  4. Participation in any other clinical trial and receipt of drug or non-drug interventions within the 3 months prior to screening;
  5. Patients unable to adhere to follow-up or receive treatment as scheduled;
  6. Other circumstances in which the investigator deems the patient unsuitable for inclusion in this clinical trial.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

240 participants in 2 patient groups

prepubertal children of short stature
Other group
Description:
prepubertal children of short stature with different Initial doses of PEG-rhGH
Treatment:
Drug: PEG-rhGH
pubertal children of short stature
Other group
Description:
pubertal children of short stature with different Initial doses of PEG-rhGH with or without GnRHa treatment
Treatment:
Drug: PEG-rhGH
Drug: GnRHa

Trial contacts and locations

0

Loading...

Central trial contact

Xiaoou Shan; Mengjie Yang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems